These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 26670218)

  • 1. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda.
    Velloza J; Celum C; Haberer JE; Ngure K; Irungu E; Mugo N; Baeten JM; Heffron R;
    AIDS Behav; 2017 Aug; 21(8):2509-2518. PubMed ID: 28634661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
    Mujugira A; Celum C; Coombs RW; Campbell JD; Ndase P; Ronald A; Were E; Bukusi EA; Mugo N; Kiarie J; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):579-84. PubMed ID: 27070123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships.
    Mujugira A; Celum C; Thomas KK; Farquhar C; Mugo N; Katabira E; Bukusi EA; Tumwesigye E; Baeten JM;
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):436-42. PubMed ID: 24798765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.
    Irungu EM; Heffron R; Mugo N; Ngure K; Katabira E; Bulya N; Bukusi E; Odoyo J; Asiimwe S; Tindimwebwa E; Celum C; Baeten JM;
    BMC Infect Dis; 2016 Oct; 16(1):571. PubMed ID: 27751179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Ngure K; Thomas KK; Katabira E; Baeten JM;
    Sex Transm Dis; 2017 Jan; 44(1):57-61. PubMed ID: 27898566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
    BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.
    Jain V; Petersen ML; Liegler T; Byonanebye DM; Kwarisiima D; Chamie G; Sang N; Black D; Clark TD; Ladai A; Plenty A; Kabami J; Ssemmondo E; Bukusi EA; Cohen CR; Charlebois ED; Kamya MR; Havlir DV;
    Lancet HIV; 2017 Mar; 4(3):e122-e133. PubMed ID: 27989576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
    Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
    BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is PrEP necessary during natural conception in HIV-1-serodiscordant couples on ART with suppressed viral load? A retrospective cohort analysis.
    Sun L; Liu A; Li J; Shao Y; Li Q; Ye J; Zhang H; Li Z; Wang H
    BMC Infect Dis; 2020 Mar; 20(1):195. PubMed ID: 32138673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
    Nachega JB; Hislop M; Nguyen H; Dowdy DW; Chaisson RE; Regensberg L; Cotton M; Maartens G
    J Acquir Immune Defic Syndr; 2009 May; 51(1):65-71. PubMed ID: 19282780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.